A study published in Vaccine underscores the significant economic and health benefits of rotavirus vaccination in low-income countries. Researchers found that introducing the rotavirus vaccine could prevent millions of cases of severe diarrhea, hospitalizations, and deaths among children under five, while also reducing healthcare costs and productivity losses. The analysis supports the World Health Organization’s (WHO) recommendation for widespread rotavirus immunization, particularly in regions with high disease burden and limited access to treatment.
The study used cost-effectiveness models to evaluate the long-term impacts of vaccination programs, demonstrating that rotavirus immunization is a highly cost-effective intervention. Investments in vaccination not only save lives but also alleviate financial strain on health systems and families. These findings reinforce the importance of sustained funding and policy commitment to ensure equitable vaccine access in low-resource settings, where the economic and health benefits are most pronounced.
Thumbnail image credit: WHO
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.